Samsung begins rollout of blood pressure monitoring feature for the Galaxy Watch Active 2 in South Korea
Samsung has yet to enable the long-anticipated ECG support on the Galaxy Watch Active 2, but the company continues to work towards making the Galaxy Watch Active 2 more useful.
Context & Ripple Effects
This rollout is the delivery of what Samsung promised two months earlier, when its blood pressure app was approved by a South Korean regulator for a Q3 launch — it arrived ahead of that window. The catch flagged at launch still stands: ECG on the Galaxy Watch Active 2 remains unenabled, so blood pressure is the first clinically regulated health feature actually shipping on the watch.
The sequencing matters because each market requires its own clearance. Samsung's later expansion of EKG support across 31 markets shows how slowly that per-country approval treadmill turns, and the eventual US blood pressure rollout — which still requires a traditional upper-arm cuff for calibration — shows the hardware constraint persisted even six years on.
First-order effects
- Korean Galaxy Watch Active 2 owners gain blood pressure readings through Samsung Health Monitor, but only after calibrating against a conventional cuff, and without the ECG function the hardware shipped expecting.
- Samsung gets a live regulated-health dataset in one market while competitors' watches offer none, turning a software update into a differentiator for the aging Active 2.
Second-order effects
- Rivals like Apple now face pressure to clear equivalent blood-pressure features with their own national regulators rather than stick to consumer-grade heart-rate metrics.
- Cuff manufacturers gain an unexpected role as mandatory accessories in the smartwatch ecosystem, since optical-only wrist readings need external calibration.
Third-order effects
- If the pattern holds, premium smartwatches bifurcate into regionally-gated medical devices — identical hardware shipping different capabilities depending on each regulator's sign-off — making approval velocity a core competitive metric.
- Calibration-dependent features push watchmakers toward hybrid models pairing wearables with clinical peripherals, and open the door to subscription health services of the kind Samsung's own health leadership later floated.
The trend: Smartwatch makers are converting consumer wearables into regulator-cleared medical devices market by market, with approval cadence — not chip capability — setting the pace for health features.